These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32860755)

  • 1. Potential Significant Changes in Nuclear Regulatory Commission Policies Regarding Training and Experience Requirements for the Use of Radiopharmaceuticals.
    Wallner PE; Lieto RP; Dillehay GL; Ghesani MV; Rosenthal SA; Rosenzweig KE; Steinberg ML; Yoo DC; Small W
    J Am Coll Radiol; 2021 Feb; 18(2):312-317. PubMed ID: 32860755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Training and Education Requirements for Authorized Users of Therapeutic Radiopharmaceuticals: Changes Under Consideration for 10CFR35.390 and Their Potential Impact.
    Wallner PE; Lieto RP; Dillehay GL; Ghesani MV; Rosenthal SA; Rosenzweig KE; Steinberg ML; Yoo DC
    J Am Coll Radiol; 2019 Nov; 16(11):1572-1576. PubMed ID: 31092343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10 CFR Part 35: changes to the NRC rule governing the medical use of radioisotopes and implications for radiologic practice.
    Foens CS; Fairobent LA; Guiberteau MJ;
    J Am Coll Radiol; 2006 Feb; 3(2):96-101. PubMed ID: 17412018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All You Need to Know as an Authorized User.
    Baldwin JA; Bag AK; White SL; Palot-Manzil FF; O'Malley JP
    AJR Am J Roentgenol; 2015 Aug; 205(2):251-8. PubMed ID: 26204272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACR-ACNM-ARS-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals.
    Wallner PE; Yoo DC; Calais J; Escorcia FE; Mari Aparici C; Michalski J; Morris M; Morris ZS; Pryma D; Rabatic BM; Sharma N; Vapiwala N; Ghesani MV; Subramaniam RM; Small W; Schechter NR
    Am J Clin Oncol; 2024 Apr; 47(4):169-176. PubMed ID: 38131352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic science curriculums in nuclear cardiology and cardiovascular imaging: evolving and emerging concepts.
    Van Decker WA; Villafana T
    J Nucl Cardiol; 2008; 15(4):587-94. PubMed ID: 18674726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for radiation protection.
    Murphy PH
    Semin Nucl Med; 1986 Apr; 16(2):131-41. PubMed ID: 3961514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening radiopharmacy practice in IAEA Member States.
    Duatti A; Bhonsle U
    Semin Nucl Med; 2013 May; 43(3):188-94. PubMed ID: 23561456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
    Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
    J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNMMI Clinical Trials Network Research Series for Technologists: Introduction.
    Frye S; Butterfield R; Hoffman JM
    J Nucl Med Technol; 2021 Dec; 49(4):297-302. PubMed ID: 34862261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP General Chapter <825> Impact on Nuclear Medicine Technology Practice.
    Hinkle GH
    J Nucl Med Technol; 2020 Jun; 48(2):106-113. PubMed ID: 32499321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRC Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive.
    J Nucl Med; 2019 Jul; 60(7):9N. PubMed ID: 31263088
    [No Abstract]   [Full Text] [Related]  

  • 13. Release of patients after therapy with unsealed radionuclides.
    International Commission on Radiological Protection
    Ann ICRP; 2004; 34(2):v-vi, 1-79. PubMed ID: 15571759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of COVID-19 on nuclear medicine and radiopharmacy activities: A global survey.
    Al-Saeedi F; Rajendran P; Tipre D; Aladwani H; Alenezi S; Alqabandi M; Alkhamis A; Redha A; Mohammad A; Ahmad F; Abdulnabi Y; Alfadhly A; Alrasheedi D
    Sci Rep; 2023 Jun; 13(1):10489. PubMed ID: 37380735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and different educational pathways for training physicians in nuclear medicine.
    Harolds JA; Smith GT; Baker SR
    Acad Radiol; 2008 Dec; 15(12):1596-603. PubMed ID: 19000877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Licensing criteria for nuclear medicine.
    Westerman BR
    Semin Nucl Med; 1986 Jul; 16(3):171-8. PubMed ID: 3749912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nuclear medicine entangled by administrative regulations].
    Meyer GJ
    Nuklearmedizin; 2013; 52(2):N11-5. PubMed ID: 23503760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
    Fed Regist; 2000 Aug; 65(150):47654-60. PubMed ID: 11067710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a harmonized radiopharmaceutical regulatory framework in Europe?
    Decristoforo A; Peñuelas I
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):394-401. PubMed ID: 19834449
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.